Katie Wright, Author at European Medical Journal - Page 39 of 45

Assisted Reproductive Technology Increases Congenital Heart Defect Risk

A study suggests a notable association between assisted reproductive technology and certain severe heart conditions, particularly in multiple pregnancies.

New Vaccine Shows Promise for Diverse Streptococcus Strains

Research explores a Streptococcus pyogenes vaccine that may offer cross-species immunity against related streptococcal strains

Understanding Long COVID and Its Lasting Health Impacts

Long COVID presents many symptoms, from fatigue to cognitive impairments. Research explores the impact of this condition and its similarities to other respiratory infections

Electronic Nudges Boost Flu Vaccination in
Chronically Ill Patients

A study has demonstrated that electronic letters informed by behavioural science can significantly increase influenza vaccination rates in chronically ill patients.

Low-Intensity Therapy Effective for Children with Certain Leukaemia Genotypes

Children with specific genetic subtypes of acute lymphoblastic leukaemia can achieve excellent outcomes with low-intensity therapy, reducing the risk of severe side effects

Shorter Radiation Course for Breast Reconstruction: ASTRO 2024

A shorter course of postmastectomy radiation therapy combined with breast reconstruction has been proven to be both safe and effective, according to a new study

Imaging Trade-Offs in Extremely Dense Breasts

New research has shed light on the trade-offs of contrast-enhanced mammography for imaging women with extremely dense breasts.

High Rates of Iron Deficiency in Pregnancy Highlight Need for Early Screening

A new study has highlighted the significant risk of iron deficiency among pregnant women, even in high-resource settings

Modified Treatment for Advanced Rectal Cancer Proves Effective

A Swedish study has shown that total neoadjuvant treatment for locally advanced rectal cancer is effective in routine healthcare settings, offering similar results to the RAPIDO trial

Residual Disease Dynamics and Prognosis in Multiple Myeloma

A UCSF study highlights the importance of MRD assessment and clonal diversity in predicting clinical outcomes for multiple myeloma patients